TalkMed tumbles 17.5% on news of CEO's eight-month suspension
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CATALIST-listed TalkMed Group saw its shares tumble 15 per cent when trading resumed at 2.00pm on Wednesday, following news that its chief executive officer, Ang Peng Tiam, had been given an eight-month suspension by the Singapore Medical Council (SMC).
Dr Ang, 59, a prominent cancer specialist and the company's main revenue contributor, was suspended after a failed appeal against a misconduct conviction. The suspension will begin on July 25, 2017.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
